As far as we know, Carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) have been used as major serum tumor markers in gastrointestinal cancers, of which the positive rates for EJA patients were only 20.3% and 12.9%, respectively [44]. Here, CEACAM5 is linked to neoplasm.